Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors during the central nervous procedure, conolidine modulates alternate molecular targets. A Science Developments examine uncovered that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide avai... https://johnc010gqc2.prublogger.com/profile